Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
This year we’ve explored critical clinical insights, cutting-edge care strategies, and expert perspectives on our podcast. Today, we’re excited to count down the five standout podcast episodes that...
As researchers continue exploring early-intervention strategies for high-risk smoldering multiple myeloma, understanding the basic pathophysiology of plasma cell disorders (and the targets of emerging...
Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
October is Breast Cancer Awareness Month. Swipe through this slideshow to explore our latest coverage highlighting the evolving science shaping breast cancer care today from approaches to surgery and...
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
Male breast cancer comprises 0.3% of all cancer in men, but men typically present with more advanced disease than women due to delayed care. This quick quiz will test your knowledge on male breast cancer...
Sexual and gender minority (SGM) patients as well as transgender and gender-diverse (TGD) patients historically face systemic barriers in healthcare. Gynecological cancer care must account for the unique...
How well do you understand the latest findings on fixed-duration acalabrutinib–venetoclax regimens in untreated chronic lymphocytic leukemia? Take this quiz to find out!
